Related content

Impact of Combined C1 Esterase Inhibitor/Coagulation Factor XIII or N-Acetylcysteine/Tirilazad Mesylate Administration on Leucocyte Adherence and Cytokine Release in Experimental Endotoxaemia

By Birnbaum J   Klotz E   Spies CD   Mueller J   Vargas Hein O   Feller J   Lehmann C  

The Journal of International Medical Research, Vol. 36, Iss. 4, 2008-07 ,pp. : 748-759

Field House Publishing

Access to resources Recommend Favorite

C1-inhibitor: an anti-inflammatory reagent with therapeutic potential

By Kirschfink Michael   Mollnes Tom Eirik  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 7, 2001-07 ,pp. : 1073-1083

Informa Healthcare

Access to resources Recommend Favorite

GPI 6150, a poly (ADP-ribose) polymerase inhibitor, exhibits an anti-inflammatory effect in rat models of inflammation

By Mazzon E.   Serraino I.   Li J.-H.   Dugo L.   Caputi A.P.   Zhang J.   Cuzzocrea S.  

European Journal of Pharmacology, Vol. 415, Iss. 1, 2001-03 ,pp. : 85-94

Elsevier

Access to resources Recommend Favorite

The use of plasma-derived C1 inhibitor in the treatment of hereditary angioedema

By Cicardi Marco   Zingale Lorenza Chiara   Zanichelli Andrea   Deliliers Daniela Lambertenghi   Caccia Sonia  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 18, 2007-12 ,pp. : 3173-3181

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of PEGylated IFN-β 1a Following Subcutaneous Administration in Monkeys

By Mager Donald E.   Neuteboom Berend   Jusko William J.  

Pharmaceutical Research, Vol. 22, Iss. 1, 2005-01 ,pp. : 58-61

Springer Publishing Company

Access to resources Recommend Favorite